- Home
- NKTX vs NMT Comparison
NKTX vs NMT Comparison
Compare NKTX & NMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTX
- NMT
- Stock Information
- Founded
- NKTX 2015
- NMT 1993
- Country
- NKTX United States
- NMT United States
- Employees
- NKTX N/A
- NMT N/A
- Industry
- NKTX Biotechnology: Pharmaceutical Preparations
- NMT Finance/Investors Services
- Sector
- NKTX Health Care
- NMT Finance
- Exchange
- NKTX Nasdaq
- NMT Nasdaq
- Market Cap
- NKTX 131.3M
- NMT 110.6M
- IPO Year
- NKTX 2020
- NMT N/A
- Fundamental
- Price
- NKTX $1.96
- NMT $11.96
- Analyst Decision
- NKTX Strong Buy
- NMT
- Analyst Count
- NKTX 6
- NMT 0
- Target Price
- NKTX $15.00
- NMT N/A
- AVG Volume (30 Days)
- NKTX 675.7K
- NMT 19.1K
- Earning Date
- NKTX 05-20-2025
- NMT 01-01-0001
- Dividend Yield
- NKTX N/A
- NMT 3.21%
- EPS Growth
- NKTX N/A
- NMT N/A
- EPS
- NKTX N/A
- NMT N/A
- Revenue
- NKTX N/A
- NMT N/A
- Revenue This Year
- NKTX N/A
- NMT N/A
- Revenue Next Year
- NKTX N/A
- NMT N/A
- P/E Ratio
- NKTX N/A
- NMT N/A
- Revenue Growth
- NKTX N/A
- NMT N/A
- 52 Week Low
- NKTX $1.31
- NMT $9.05
- 52 Week High
- NKTX $8.23
- NMT $10.93
- Technical
- Relative Strength Index (RSI)
- NKTX 53.68
- NMT 63.56
- Support Level
- NKTX $1.81
- NMT $11.65
- Resistance Level
- NKTX $2.16
- NMT $11.86
- Average True Range (ATR)
- NKTX 0.16
- NMT 0.16
- MACD
- NKTX -0.01
- NMT 0.05
- Stochastic Oscillator
- NKTX 38.32
- NMT 96.92
About NKTX Nkarta Inc.
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
About NMT Nuveen Massachusetts Quality Municipal Income Fund
Nuveen Massachusetts Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's objective seeks to provide current income exempt from both regular federal and Massachusetts income taxes by investing in a portfolio of municipal obligations issued by state and local government authorities within a single state or certain U.S. territories.